Premature Ventricular Contractions (PVCs) and Blood Pressure Control
Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if reduction in premature ventricular contraction
(PVC) burden results in a decrease in blood pressure, sympathetic outflow, plasma
catecholamines and an improvement in baroreflex gain. Flecainide will be used for PVC
suppression in a randomized, double-blinded, crossover fashion.